Sixth Street Partners Management Company »

Mineralys Therapeutics shares owned by Sixth Street Partners Management Company

Quarter-by-quarter ownership of Mineralys Therapeutics (MLYS) shares owned by Sixth Street Partners Management Company from 13F filings

Historical chart of Sixth Street Partners Management Company investment in Mineralys Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mineralys Therapeutics held by Sixth Street Partners Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mineralys Therapeutics by Sixth Street Partners Management Company

Quarter filed Position value Share count Share price at filing
2026-06-30 $14M 521k 26.98

More positions owned by Sixth Street Partners Management Company

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Schwab Strategic Tr Fundamental Us L (FNDX)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
UnitedHealth (UNH)
Tesla Motors (TSLA)
Micron Technology (MU)
Schwab Strategic Tr Fundamental Intl (FNDF)
Eli Lilly & Co. (LLY)
Home Depot (HD)

View all positions for Sixth Street Partners Management Company

Top funds holding Mineralys Therapeutics

Catalys Pacific
RA Capital Management
BlackRock
Samsara BioCapital
FMR
Deerfield Management Company
State Street Corporation
Armistice Capital
Vanguard Capital Management
Laurion Capital Management
OrbiMed Advisors
Troluce Capital Advisors
Franklin Resources
Andera Partners
Geode Capital Management

View all funds holding Mineralys Therapeutics